Industries > Pharma > Global Translational Regenerative Medicine Market Prospects 2017-2027

Global Translational Regenerative Medicine Market Prospects 2017-2027

Stem Cell Therapies, Tissue Engineered Products, Gene Therapies

PUBLISHED: 05 April 2017
PAGES: 316
PRODUCT CODE: PHA0183

Clear
WOOCS 2.2.1
SKU: PHA0183 Categories: , ,

The translational regenerative medicine market has been undergoing considerable changes over the last few years. There are a number of therapies that have been launched into the market over the last few years. Stem cell therapies are being developed constantly and these are targeted at various indications, from the more common cardiovascular conditions to rarer orphan indications.

The Global Translational Regenerative Medicine market is expected to grow significantly over the forecast period. The Global Translational Regenerative Medicine market was valued at $5.8bn in 2016. Visiongain forecasts this market to increase to $14.5bn in 2021. The market is estimated to grow at a CAGR of 19.9% in the first half of the forecast period and 17.7% from 2016 to 2027.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new report you find 316-page report you will receive 107 tables and 66 figures – all unavailable elsewhere.

The 316-page report provides clear detailed insight into the Global Translational Regenerative Medicine market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand new report today you stay better informed and ready to act.

Global Translational Regenerative Medicine Market Prospects 2017-2027

Report Scope
Global Translational Regenerative Medicine market forecasts from 2017-2027

• Translational Regenerative Medicine regional market forecasts from 2017-2027, covering:
– United States
– Europe
– Asia-Pacific
– Rest of the World

• Global Translational Regenerative Medicine submarket forecasts from 2017-2027 covering:
– Stem Cell Therapies
– Tissue Engineered Products
– Gene Therapies

• Forecasts from 2017-2027 of the leading products in the Global Translational Regenerative Medicine market:
– Osteocel Plus
– Trinity ELITE
– TEMCELL /Prochymal
– Apligraf
– Dermagraft
– Epifix
– ReCell
– Neovasculgen
– Glybera (alipogene tiparvovec)
– IMLYGIC (talimogene laherparepvec)

• Assessment of the leading companies in the Global Translational Regenerative Medicine market:
– Alphatec Spine
– Anterogen
– Athersys
– Avita Medical
– AxoGen
– Medipost
– Mesoblast
– NuVasive
– Ocata Therapeutics
– Organogenesis
– Osiris Therapeutics
– Pharmicell
– Regenerys
– TiGenix
– UniQure
– Vericel Corporation

SWOT and Porter’s Five Force analysis of the translational regenerative medicine market

Visiongain’s study is intended for anyone requiring commercial analyses for the Translational Regenerative Medicine Market and leading companies. You find data, trends and predictions.

Buy our report today Global Translational Regenerative Medicine Market Analysis: Stem Cell Therapies, Tissue Engineered Products, Gene Therapies.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Download sample pages

Complete the form below to download your free sample pages for Global Translational Regenerative Medicine Market Prospects 2017-2027


Download sample pages

Complete the form below to download your free sample pages for Global Translational Regenerative Medicine Market Prospects 2017-2027


Latest Pharma news

Visiongain Publishes Cancer Diagnostics Market Report 2021-2031

Major investments have been made by companies in the cancer diagnostics industry in the past few years to develop novel tests to capitalize on the opportunities in the untapped market.

19 April 2021

READ

Visiongain Publishes Food for Special Medical Purpose (FSMP) Market Report 2020-2030

The food for special medical purpose (FSMP) market growth can be attributed to the growing prevalence of metabolic diseases, growing consumer unhealthy lifestyle, and surge in demand from emerging economies such as Asia Pacific, Middle East & Africa, Latin America, and others.

12 April 2021

READ

Visiongain Publishes Cell-Based Assays Market Report to 2030

Growing incidence of chronic diseases; increasing R&D investment for drug discovery research and Growing Adoption of High-Throughput Screening Methodologies are some of the major factors that propel the market growth.

09 April 2021

READ

Visiongain Publishes Cancer Biologics Therapies Market Report 2021-2031

The main drivers for the growth include technological advancements in the development of novel biomarkers, rising preference for minimally or less invasive surgeries, increasing cancer awareness leading to growth in cancer cases, and growing disposable income in emerging economies.

06 April 2021

READ

Categories